Back to results
US 2013/0096165 A1Published application
Compounds and methods for modulating g protein-coupled receptors
AssigneeIrm LLC
InventorsXiaohui He, Xuefeng Zhu, Kunyong Yang, Robert Epple, Hong Liu
Life of this patent
Estimating the term…
Abstract
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with or mediated by G protein-coupled receptors, in particular G protein-coupled receptor 120.
Claims22
A compound of Formula (I):
- wherein:
- n is selected from 0, 1, 2, 3 and 4;
- A is selected from:
- A is:
- R8 is selected from H, C1-4alkyl and phenyl optionally substituted with 1 to 3 radicals independently selected from halo, C1-4alkyl, halo-substitued-C1-4alkyl, C1-4alkoxy and halo-substituted-C1-4alkoxy;
- R1 is selected from —COOH, —SO3H and tetrazolyl;
- R2 is selected from halo, C1-4alkyl, halo-substitued-C1-4alkyl, C1-4alkoxy and halo-substituted-C1-4alkoxy;
- R3, R4, R5, R6 or R7 are independently selected from H, cyano, hydroxyl, nitro, halo, C1-4alkyl, halo-substitued-C1-4alkyl, C1-4alkoxy, halo-substituted-C1-4alkoxy, X2OR11, —X2NR12R13, —X2R11, —X2OX3R11 and —X2OX3OR11;
- wherein X2 is selected from a bond and C1-4alkylene;
- X3 is C1-4alkylene;
- R11 is selected from C1-6alkyl, heteroaryl and aryl, each optionally substituted with 1 to 3 radicals independently selected from halo, cyano, hydroxyl, nitro, amino, C1-4alkyl, halo-substitued-C1-4alkyl, C1-4alkoxy and halo-substituted-C1-4alkoxy;
- R12 and R13 are independently selected from H and C1-6alkyl;
- or
- R3 and R4 or R5 and R6 are each independently C1-4alkyl and taken together with the carbon atoms to which they are attached can form a phenyl ring;
- wherein said phenyl of the combination of R3 and R4 or R5 and R6 is optionally substituted with 1 to 3 radicals independently selected from cyano, amino, hydroxyl, nitro, halo, C1-4alkyl, halo-substitued-C1-4alkyl, C1-4alkoxy and halo-substituted-C1-4alkoxy;
- or the pharmaceutically acceptable salts thereof.
13 more elements
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.